Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review)

Infectious complications are the most common cause of death in patients with severe burns. To date, there is no generally accepted method for preventing such complications in burn injury. One of the possible prevention options is selective intestinal decontamination (SID). This method is based on the enteral administration of non-absorbable antimicrobial agents. The preventive effect of SID involves inhibition of intestinal microflora translocation through the mucous membranes, inasmuch as studies demonstrate that endogenous opportunistic microorganisms are a common cause of infectious complications in various critical conditions.

The SID method was originally developed in the Netherlands for patients suffering from mechanical injury. Antimicrobial drugs were selected based on their high activity in relation to the main endogenous opportunistic pathogens and minimal activity against normal intestinal microflora components. The combination of polymyxin (B or E), tobramycin, and amphotericin B with intravenous cefotaxime was chosen as the first SID regimen. Other regimens were proposed afterwards, and the application field of the method was expanded. In particular, it became the method of choice for prevention of infectious complications in patients with severe burn injury.

Clinical studies demonstrate efficacy of some SID regimens for preventing infectious complications in patients with thermal injury. Concomitant administration of SID and systemic preventive antibiotics and addition of oropharyngeal decontamination increases the method efficacy. SID is generally well-tolerated, but some studies show an increased risk of diarrhea with this preventive option. In addition, SID increases the risk of developing antibiotic resistance like any other antibiotic regimens.

1. Jeschke M.G., Pinto R., Kraft R., Nathens A.B., Finnerty C.C., Gamelli R.L., Gibran N.S., Klein M.B., Arnoldo B.D., Tompkins R.G., Herndon D.N.; Inflammation and the Host Response to Injury Collaborative Research Program. Morbidity and survival probability in burn patients in modern burn care. Crit Care Med 2015; 43(4): 808–815, https://doi.org/10.1097/ccm.0000000000000790.
2. Litt J.S. Evaluation and management of the burn patient: a case study and review. Mo Med 2018; 115(5): 443–446.
3. Zhylinski E.V., Chasnoits A.C., Alekseev S.A., Doroshenko G.V. Analisys of lethality, main prognostic factors and complications in burn patients. Medicinskie novosti 2014; 11: 87–91.
4. Evdokimov V.I., Kourov A.S. Genesis of research on burn injury (analysis of domestic articles in 2005–2017). Mediko-biologicheskie i socialʹno-psihologicheskie problemy bezopasnosti v chrezvychajnyh situaciah 2018; 4: 108–120, https://doi.org/10.25016/2541-7487-2018-0-4-108-120.
5. Fomicheva T.D., Turkutyukov V.B., Sotnichenko S.A., Terekhoy S.M., Skurikhina Yu.E., Okrokov M.V. Microbiological monitoring in the epidemiological surveillance system for purulent-septic infections in case of burn injury. Tihookeanskij medicinskij zurnal 2018; 3: 72–74.
6. Obeid D.A., Alhujayri A.K., Aldekhayel S. Burn-induced neuroepithelial changes as a delayed cause of mortality in major burns: a case report and literature review. Int J Burns Trauma 2018; 8(6): 145–148.
7. Lal S., Yadav G.K., Gupta R., Shrivastava G.P., Singh S., Bain J. Mortality pattern of burn patients admitted in S.G.M. Hospital Rewa: a teaching institute of central India. J Sci Soc 2012; 39(3): 130–135, https://doi.org/10.4103/0974-5009.105917.
8. Manning J. Sepsis in the burn patient. Crit Care Nurs Clin North Am 2018; 30(3): 423–430, https://doi.org/10.1016/j.cnc.2018.05.010.
9. Brusselaers N., Monstrey S., Vogelaers D., Hoste E., Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care 2010; 14(5): R188, https://doi.org/10.1186/cc9300.
10. Barsuk A.L., Lovczova L.V., Nekaeva E.S., Sorokina Yu.A. Current state and prospects of antibiotic prophylaxis in patients after burn injury. Saratovskij nauchno-medicinskij zhurnal 2019; 15(1): 108–113.
11. Ramos G., Cornistein W., Cerino G.T., Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. J Hosp Infect 2017; 97(2): 105–114, https://doi.org/10.1016/j.jhin.2017.06.015.
12. Csenkey A., Jozsa G., Gede N., Pakai E., Tinusz B., Rumbus Z., Lukacs A., Gyongyi Z., Hamar P., Sepp R., Romanovsky A.A., Hegyi P., Vajda P., Garami A. Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: a meta-analysis. PLoS One 2019; 14(9): e0223063, https://doi.org/10.1371/journal.pone.0223063.
13. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003; 361(9356): 512–519, https://doi.org/10.1016/s0140-6736(03)12489-0.
14. Krueger W.A., Unertl K.E. Selective decontamination of the digestive tract. Curr Opin Crit Care 2002; 8(2): 139–144, https://doi.org/10.1097/00075198-200204000-00009.
15. Silvestri L., de la Cal M.A., van Saene H.K. Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med 2012; 38(11): 1738–1750, https://doi.org/10.1007/s00134-012-2690-1.
16. Vaishnavi С. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol 2013; 31(4): 334–342, https://doi.org/10.4103/0255-0857.118870.
17. Earley Z.M., Akhtar S., Green S.J., Naqib A., Khan O., Cannon A.R., Hammer A.M., Morris N.L., Li X., Eberhardt J.M., Gamelli R.L., Kennedy R.H., Choudhry M.A. Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation. PLoS One 2015; 10(7): e0129996, https://doi.org/10.1371/journal.pone.0129996.
18. Cuthbertson B.H. Selective decontamination of the digestive tract in critical care: a teenage angst or coming of age issue? Crit Care 2018; 22(1): 296, https://doi.org/10.1186/s13054-018-2227-2.
19. Kurrle E., Dekker A.W., Gaus W., Haralambie E., Krieger D., Rozenberg-Arska M., de Vries-Hospers H.G., van der Waaij D., Wendt F. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection 1986; 14(5): 226–232, https://doi.org/10.1007/bf01644268.
20. Zandstra D.F., van Saene H.K. Chris Stoutenbeek and selective digestive decontamination. Intensive Care Med 2007; 33(2): 207–208, https://doi.org/10.1007/s00134-006-0456-3.
21. Stoutenbeek C.P., Miranda D.R., van Saene H.K.F. A new technique for infection prevention in the intensive care unit. Proceedings of the 6th European Congress of Anaesthesiology. Anaesthesia 1982; 56: 98.
22. van Saene H.K.F., Rommes H.J., Zandstra D.F. The history of selective decontamination of the digestive tract. In: Selective digestive tract decontamination in intensive care medicine. van der Voort P.H.J., van Saene H.K.F. (editors). Springer; 2008; р. 1–5.
23. Fralick M., Macdonald E.M., Gomes T., Antoniou T., Hollands S., Mamdani M.M., Juurlink D.N.; Canadian Drug Safety and Effectiveness Research Network. Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ 2014; 349: g6196, https://doi.org/10.1136/bmj.g6196.
24. Neu H.C. Tobramycin: an overview. J Infect Dis 1976; 134(Suppl. S3): 19, https://doi.org/10.1093/infdis/134.supplement_1.s3.
25. Hazenberg M.P., Pennock-Schröder A.M., Van den Boom M., Van de Merwe J.P. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces. J Hyg (Lond) 1984; 93(1): 27–34, https://doi.org/10.1017/s0022172400060897.
26. Selective digestive tract decontamination in intensive care medicine: a practical guide to controlling infection. van der Voort P.H.J., van Saene H.K.F. (editors). Springer Milan; 2008, https://doi.org/10.1007/978-88-470-0653-9.
27. Li J., Zhu L., Xu M., Han J., Bai X., Yang X., Zhu H., Xu J., Zhang X., Gong Y., Hu D., Gao F. Selective decontamination of the digestive tract ameliorates severe burn-induced insulin resistance in rats. Burns 2015; 41(5): 1076–1085, https://doi.org/10.1016/j.burns.2014.12.018.
28. Chan M.X.F., Buitinck S., Stooker W., Haak E.A.F., Wester J.P.J., Bosman R.J., van der Voort P.H.J. Clinical effects of perioperative selective decontamination of the digestive tract (SDD) in cardiac surgery: a propensity score matched cohort analysis. J Cardiothorac Vasc Anesth 2019; 33(11): 3001–3009, https://doi.org/10.1053/j.jvca.2019.04.013.
29. Hofstra W., de Vries-Hospers H.G., van der Waaij D. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses. Infection 1982; 10(4): 223–227, https://doi.org/10.1007/bf01666915.
30. Guiot H.F., van Furth R. Selective decontamination in bone marrow transplant recipients. Epidemiol Infect 1992; 109(3): 349–360, https://doi.org/10.1017/s0950268800050342.
31. Hurley J.C. Is selective decontamination of the digestive tract safe? Clin Infect Dis 2015; 60(11): 1729–1730, https://doi.org/10.1093/cid/civ125.
32. Harkins C.P., Pichon B., Doumith M., Parkhill J., Westh H., Tomasz A., de Lencastre H., Bentley S.D., Kearns A.M., Holden M.T.G. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol 2017; 18(1): 130, https://doi.org/10.1186/s13059-017-1252-9.
33. Burdet C., Grall N., Linard M., Bridier-Nahmias A., Benhayoun M., Bourabha K., Magnan M., Clermont O., d’Humières C., Tenaillon O., Denamur E., Massias L., Tubiana S., Alavoine L., Andremont A., Mentré F., Duval X.; CEREMI Group. Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens. Antimicrob Agents Chemother 2019; 63(6): e02244-18, https://doi.org/10.1128/aac.02244-18.
34. Ravensbergen S.J., Louka C., Ott A., Rossen J.W., Cornish D., Pournaras S., Bathoorn E., Stienstra Y. Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands. Antimicrob Resist Infect Control 2019; 8: 6, https://doi.org/10.1186/s13756-018-0455-5.
35. Stoutenbeek C.P., van Saene H.K., Miranda D.R., Zandstra D.F. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg 1983; 34(3): 209–221.
36. Stoutenbeek C.P., van Saene H.K., Little R.A., Whitehead A.; Working Group on Selective Decontamination of the Digestive Tract. The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients: a multicenter randomized controlled trial. Intensive Care Med 2007; 33(2): 261–270, https://doi.org/10.1007/s00134-006-0455-4.
37. de Jonge E. Effects of selective decontamination of digestive tract on mortality and antibiotic resistance in the intensive-care unit. Curr Opin Crit Care 2005; 11(2): 144–149, https://doi.org/10.1097/01.ccx.0000155352.01489.11.
38. de Jonge E., Schultz M.J., Spanjaard L., Bossuyt P.M., Vroom M.B., Dankert J., Kesecioglu J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362(9389): 1011–1016, https://doi.org/10.1016/s0140-6736(03)14409-1.
39. de Jonge E., de Wilde R.B.P., Juffermans N.P., Oostdijk E.A.N., Bernards A.T., van Essen E.H.R., Kuijper E.J., Visser C.E., Kesecioglu J., Bonten M.J.M. Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD). Crit Care 2018; 22(1): 243, https://doi.org/10.1186/s13054-018-2170-2.
40. Price R., MacLennan G., Glen J.; SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014; 348: g2197, https://doi.org/10.1136/bmj.g2197.
41. Roquilly A., Marret E., Abraham E., Asehnoune K. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis 2015; 60(1): 64–75, https://doi.org/10.1093/cid/ciu740.
42. Kesecioglu J., Eggimann P. What is new in selective decontamination of the digestive tract? Intensive Care Med 2016; 42(8): 1270–1275, https://doi.org/10.1007/s00134-015-4009-5.
43. Wittekamp B.H.J., Oostdijk E.A.N., Cuthbertson B.H., Brun-Buisson C., Bonten M.J.M. Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review. Intensive Care Med 2020; 46(2): 343–349, https://doi.org/10.1007/s00134-019-05883-9.
44. Abis G.S., Stockmann H.B., van Egmond M., Bonjer H.J., Vandenbroucke-Grauls C.M., Oosterling S.J. Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review. J Gastrointest Surg 2013; 17(12): 2172–2178, https://doi.org/10.1007/s11605-013-2379-y.
45. Abis G.S.A., Stockmann H.B.A.C., Bonjer H.J., van Veenendaal N., van Doorn-Schepens M.L.M., Budding A.E., Wilschut J.A., van Egmond M., Oosterling S.J.; SELECT trial study group. Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial). Br J Surg 2019; 106(4): 355–363, https://doi.org/10.1002/bjs.11117.
46. Roos D., Dijksman L.M., Tijssen J.G., Gouma D.J., Gerhards M.F., Oudemans-van Straaten H.M. Systematic review of perioperative selective decontamination of the digestive tract in elective gastrointestinal surgery. Br J Surg 2013; 100(12): 1579–1588, https://doi.org/10.1002/bjs.9254.
47. Wirth U., Rogers S., Haubensak K., Schopf S., von Ahnen T., Schardey H.M. Local antibiotic decontamination to prevent anastomotic leakage short-term outcome in rectal cancer surgery. Int J Colorectal Dis 2018; 33(1): 53–60, https://doi.org/10.1007/s00384-017-2933-2.
48. Reibetanz J., Germer C.T. Selektive Darmdekontamination im Rahmen der onkologischen Kolorektalchirurgie. Chirurg 2019; 90(4): 326, https://doi.org/10.1007/s00104-019-0939-8.
49. Flemming S., Germer C.T. Orale Antibiotikaprophylaxe zur Darmdekontamination vor elektiver kolorektaler Chirurgie. Chirurg 2020; 91(2): 128–133, https://doi.org/10.1007/s00104-019-01079-5.
50. Waked K., Schepens M. State-of the-art review on the renal and visceral protection during open thoracoabdominal aortic aneurysm repair. J Vis Surg 2018; 4: 31, https://doi.org/10.21037/jovs.2018.01.12.
51. Safdar N., Said A., Lucey M.R. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transpl 2004; 10(7): 817–827, https://doi.org/10.1002/lt.20108.
52. Kawecki D., Pacholczyk M., Lagiewska B., Sawicka-Grzelak A., Durlik M., Mlynarczyk G., Chmura A. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc 2014; 46(8): 2777–2781, https://doi.org/10.1016/j.transproceed.2014.08.031.
53. Resino E., San-Juan R., Aguado J.M. Selective intestinal decontamination for the prevention of early bacterial infections after liver transplantation. World J Gastroenterol 2016; 22(26): 5950–5957, https://doi.org/10.3748/wjg.v22.i26.5950.
54. Whangbo J., Ritz J., Bhatt A. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017; 52(2): 183–190, https://doi.org/10.1038/bmt.2016.206.
55. Fujiya Y., Nagamatsu M., Tomida J., Kawamura Y., Yamamoto K., Mawatari M., Kutsuna S., Takeshita N., Hayakawa K., Kanagawa S., Mezaki K., Hashimoto M., Ishii S., Ohmagari N. Successful treatment of recurrent Helicobacter fennelliae bacteraemia by selective digestive decontamination with kanamycin in a lung cancer patient receiving chemotherapy. JMM Case Rep 2016; 3(5): e005069, https://doi.org/10.1099/jmmcr.0.005069.
56. Mürner C.M., Stenner-Liewen F., Seifert B., Mueller N.J., Schmidt A., Renner C., Schanz U., Knuth A., Manz M.G., Scharl M., Gerber B., Samaras P. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation. Leuk Lymphoma 2019; 60(3): 685–695, https://doi.org/10.1080/10428194.2018.1496332.
57. van Saene H.K.F., Petros A.J., Ramsay G., Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 2003; 29(5): 677–690, https://doi.org/10.1007/s00134-003-1722-2.
58. Silvestri L., van Saene H.K., Weir I., Gullo A. Survival benefit of the full selective digestive decontamination regimen. J Crit Care 2009; 24(3): 474.e7–474.e14, https://doi.org/10.1016/j.jcrc.2008.11.005.
59. de La Cal M.A., Cerdá E., García-Hierro P., van Saene H.K., Gómez-Santos D., Negro E., Lorente J.A. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Ann Surg 2005; 241(3): 424–430, https://doi.org/10.1097/01.sla.0000154148.58154.d5.
60. López-Rodríguez L., de la Cal M.A., García-Hierro P., Herrero R., Martins J., van Saene H.K., Lorente J.A. Selective digestive decontamination attenuates organ dysfunction in critically ill burn patients. Shock 2016; 46(5): 492–497, https://doi.org/10.1097/shk.0000000000000664.
61. Mackie D.P., van Hertum W.A., Schumburg T., Kuijper E.C., Knape P. Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries. J Trauma 1992; 32(5): 570–575.
62. Mackie D.P., van Hertum W.A., Schumburg T.H., Kuijper E.C., Knape P., Massaro F. Reduction in Staphylococcus aureus wound colonization using nasal mupirocin and selective decontamination of the digestive tract in extensive burns. Burns 1994; 20(Suppl 1): S14–S17, https://doi.org/10.1016/0305-4179(94)90082-5.
63. Toscano Olivo T.E., de Melo E.C., Rocha C., Fortaleza C.M. Risk factors for acquisition of Methicillin-resistant Staphylococcus aureus among patients from a burn unit in Brazil. Burns 2009; 35(8): 1104–1111, https://doi.org/10.1016/j.burns.2009.02.008.
64. Collier Z.J., Gottlieb L.J., Alverdy J.C. Stochasticity among antibiotic-resistance profiles of common burn-related pathogens over a six-year period. Surg Infect (Larchmt) 2017; 18(3): 327–335, https://doi.org/10.1089/sur.2016.191.
65. Chen K., Lin S., Li P., Song Q., Luo D., Liu T., Zeng L., Zhang W. Characterization of Staphylococcus aureus isolated from patients with burns in a regional burn center. Southeastern China. BMC Infect Dis 2018; 18(1): 51, https://doi.org/10.1186/s12879-018-2955-6.
66. Kalligeros M., Shehadeh F., Karageorgos S.A., Zacharioudakis I.M., Mylonakis E. MRSA colonization and acquisition in the burn unit: A systematic review and meta-analysis. Burns 2019; 45(7): 1528–1536, https://doi.org/10.1016/j.burns.2019.05.014.
67. Samartsev V.A., En’cheva Yu.A., Kuznetsova M.V., Karpunina T.I. Features of infection of burn wounds. Novosti khirurgii 2014; 22(2): 199–206.
68. Khokhlova O.E., Peryanova O.V., Vladimirov I.V., Matskevich V.A., Potkina N.K., Kapshuk D.N., Kopytko L.N., Gostev V.V., Sidorenko S.V., Iwao Y., Yamamoto T. Microbiological monitoring of purulent complications in burn patients and molecular genetic features of methicillin-resistant Staphylococcus aureus (MRSA). Antibiotiki i khimioterapiya 2017; 62(9–10): 27–33.
69. Doroshenko G.V., Morozova A.V., Bochanova E.N., Degtyarev D.I., Klimets A.A., Babushkin V.A., Kurts E.M., Kopytko L.N., Sarmatova N.I., Khokhlova O.E. Assessment of the microbial landscape and the consumption of antimicrobial drugs in the burn intensive care unit of the regional clinical hospital in Krasnoyarsk. Sovremennye problemy nauki i obrazovaniya 2019; 2.
70. Cerdá E., Abella A., de la Cal M.A., Lorente J.A., García-Hierro P., van Saene H.K., Alía I., Aranguren A. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study. Ann Surg 2007; 245(3): 397–407, https://doi.org/10.1097/01.sla.0000250418.14359.31.
71. Rubio-Regidor M., Martín-Pellicer A., Silvestri L., van Saene H.K.F., Lorente J.A., de la Cal M.A. Digestive decontamination in burn patients: a systematic review of randomized clinical trials and observational studies. Burns 2018; 44(1): 16–23, https://doi.org/10.1016/j.burns.2017.04.001.
72. Avni T., Levcovich A., Ad-El D.D., Leibovici L., Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 2010; 340: c241, https://doi.org/10.1136/bmj.c241.
73. Barajas-Nava L.A., López-Alcalde J., Roqué i Figuls M., Solà I., Bonfill Cosp X. Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev 2013; 6: CD008738, https://doi.org/10.1002/14651858.cd008738.pub2.
74. Jarrett F., Balish E., Moylan J.A., Ellerbe S. Clinical experience with prophylactic antibiotic bowel suppression in burn patients. Surgery 1978; 83(5): 523–527.
75. Deutsch D.H., Miller S.F., Finley R.K. Jr. The use of intestinal antibiotics to delay or prevent infections in patients with burns. J Burn Care Rehabil 1990; 11(5): 436–442, https://doi.org/10.1097/00004630-199009000-00011.
76. Manson W.L., Klasen H.J., Sauer E.W., Olieman A. Selective intestinal decontamination for prevention of wound colonization in severely burned patients: a retrospective analysis. Burns 1992; 18(2): 98–102, https://doi.org/10.1016/0305-4179(92)90002-c.
77. Shalaby H.A., Higazi M., El Far N. Selective gastrointestinal decontamination and burn wound sepsis. Ann Burns Fire Disasters 1998; 11(1): 1–6.
78. Barret J.P., Jeschke M.G., Herndon D.N. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001; 27(5): 439–445, https://doi.org/10.1016/s0305-4179(00)00147-9.
79. Aboelatta Y.A., Abd-Elsalam A.M., Omar A.H., Abdelaal M.M., Farid A.M. Selective digestive decontamination (SDD) as a tool in the management of bacterial translocation following major burns. Ann Burns Fire Disasters 2013; 26(4): 182–188.
80. Mol M., van Kan H.J., Schultz M.J., de Jonge E. Systemic tobramycin concentrations during selective decontamination of the digestive tract in intensive care unit patients on continuous venovenous hemofiltration. Intensive Care Med 2008; 34(5): 903–906, https://doi.org/10.1007/s00134-008-1020-0.
81. Oudemans-van Straaten H.M., Endeman H., Bosman R.J., Attema-de Jonge M.E., van Ogtrop M.L., Zandstra D.F., Franssen E.J. Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study. Crit Care 2011; 15(5): R240, https://doi.org/10.1186/cc10489.
82. Möhlmann J.E., van Luin M., Mascini E.M., van Leeuwen H.J., de Maat M.R. Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation. Eur J Clin Pharmacol 2019; 75(6): 831–836, https://doi.org/10.1007/s00228-019-02644-x.
83. van Beurden Y.H., Dekkers O.M., Bomers M.K., Kaiser A.M., van Houdt R., Knetsch C.W., Girbes A.R., Mulder C.J., Vandenbroucke-Grauls C.M. An outbreak of clostridium difficile ribotype 027 associated with length of stay in the intensive care unit and use of selective decontamination of the digestive tract: a case control study. PLoS One 2016; 11(8): e0160778, https://doi.org/10.1371/journal.pone.0160778.
84. Lloréns-Villar Y., Tusell F., Canut A., Barrasa H., Corral E., Martín A., Rodríguez-Gascón A. Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study. J Antimicrob Chemother 2019; 74(8): 2289–2294, https://doi.org/10.1093/jac/dkz186.
85. van Essen E.H., de Jonge E. Selective decontamination of the digestive tract (SDD): is the game worth the candle? Semin Respir Crit Care Med 2011; 32(2): 236–242, https://doi.org/10.1055/s-0031-1275536.
86. Daneman N., Sarwar S., Fowler R.A., Cuthbertson B.H. SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13(4): 328–341, https://doi.org/10.1016/s1473-3099(12)70322-5.
87. Buitinck S., Jansen R., Rijkenberg S., Wester J.P.J., Bosman R.J., van der Meer N.J.M., van der Voort P.H.J. The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study. Crit Care 2019; 23(1): 208, https://doi.org/10.1186/s13054-019-2480-z.
88. Buelow E., Gonzalez T.B., Versluis D., Oostdijk E.A., Ogilvie L.A., van Mourik M.S., Oosterink E., van Passel M.W., Smidt H., D’Andrea M.M., de Been M., Jones B.V., Willems R.J., Bonten M.J., van Schaik W. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother 2014; 69(8): 2215–2223, https://doi.org/10.1093/jac/dku092.
89. Buelow E., Bello González T.D.J., Fuentes S., de Steenhuijsen Piters W.A.A., Lahti L., Bayjanov J.R., Majoor E.A.M., Braat J.C., van Mourik M.S.M., Oostdijk E.A.N., Willems R.J.L., Bonten M.J.M., van Passel M.W.J., Smidt H., van Schaik W. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome 2017; 5(1): 88, https://doi.org/10.1186/s40168-017-0309-z.
90. Oostdijk E.A.N., Kesecioglu J., Schultz M.J., Visser C.E., de Jonge E., van Essen E.H.R., Bernards A.T., Purmer I., Brimicombe R., Bergmans D., van Tiel F., Bosch F.H., Mascini E., van Griethuysen A., Bindels A., Jansz A., van Steveninck F.A.L., van der Zwet W.C., Fijen J.W., Thijsen S., de Jong R., Oudbier J., Raben A., van der Vorm E., Koeman M., Rothbarth P., Rijkeboer A., Gruteke P., Hart-Sweet H., Peerbooms P., Winsser L.J., van Elsacker-Niele A.W., Demmendaal K., Brandenburg A., de Smet A.M.G.A., Bonten M.J.M. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA 2014; 312(14): 1429–1437, https://doi.org/10.1001/jama.2014.7247.
91. Dahms R., Carlson M., Lohr B., Beilman G. Selective digestive tract decontamination and vancomycin-resistant enterococcus isolation in the surgical intensive care unit. Shock 2000; 14(3): 343–346, https://doi.org/10.1097/00024382-200014030-00018.
92. Laupland K.B., Fisman D.N. Selective digestive tract decontamination: а tough pill to swallow. Can J Infect Dis Med Microbiol 2009; 20(1): 9–11, https://doi.org/10.1155/2009/290130.
93. Gopalsamy S.N., Woodworth M.H., Wang T., Carpentieri C.T., Mehta N., Friedman-Moraco R.J., Mehta A.K., Larsen C.P., Kraft C.S. The use of microbiome restoration therapeutics to eliminate intestinal colonization with multidrug-resistant organisms. Am J Med Sci 2018; 356(5): 433–440, https://doi.org/10.1016/j.amjms.2018.08.015.
94. Myl’nikov A.G., Shapoval’yants S.G., Pan’kov A.G., Korolev S.V. The enteral tube feeding and selective intestinal decontamination for the treatment of the acute pancreatitis. Khirurgiya. Zhurnal im. N.I. Pirogova 2012; 2: 37–41.
95. Mylnikov A.G., Korolev S.V. Pathophisiological and clinical justification of early enteral nutrition and selective gut decontamination in acute destructive pancreatitis (literature review). Vestnik RGMU 2012; 2: 14–17.
96. Klimovich I.N., Maskin S.S., Levchenko S.A., Zemlyakov D.S., Aleksandrov V.V. Diagnosis and triatment the syndrome of intestinal insufficiency of patients with acute pancreatitis (review). Sovremennye problemy nauki i obrazovaniya 2014; 5: 508.
97. Shevtsov V.V. Sostoyanie mikrobioty dykhatel’nykh putey i kishechnika u bol’nykh rakom legkogo, assotsiirovannogo s KhOBL, i metody ee korrektsii. Avtoref. dis. … kand. med. nauk [The state of the microbiota of the respiratory tract and intestines in patients with lung cancer associated with COPD, and methods for its correction. PhD Thesis]. Moscow; 2017.
98. Kulabukhov V.V., Kudryavtsev A.N. Prevention and treatment of sepsis in patients with liver failure. Vysokotekhnologicheskaya meditsina 2015; 1(2): 22–27.
99. Gromov A.L., Zykin A.G. The comparative analysis of biomarkers of the inflammation at patients with progressing odontogenny phlegmons at treatment by selective dekontaminations method of intestines. Khirurgicheskaya stomatologiya i implantologiya 2014; 10(1): 43–45.
100. Beloborodova N.V. Current potential for antibiotic prophylaxis in surgery. Farmateka 2009; 16: 38–42.
101. Gosudarstvennyy reestr lekarstvennykh sredstv [State register of medicines]. URL:http://grls.rosminzdrav.ru.

Barsuk A.L., Nekaeva E.S., Lovtsova L.V., Urakov A.L. Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review). Sovremennye tehnologii v medicine 2020; 12(6): 86, https://doi.org/10.17691/stm2020.12.6.10